Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vildagliptin to pioglitazone added to metformin in type 2 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)
  • Vildagliptin (vildagliptin)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2015-03-17